Change Country
Welcome to LuxembourgWelcome
Please read the important information below before continuing to our website

The Lyxor ETFs on this website may be restricted for certain individuals or in certain countries pursuant to the national regulations applicable to those individuals or countries. It is therefore your responsibility to ensure that you are authorised to invest in the Lyxor ETFs on this website. 


If you are an investor in the United Kingdom, please go to  

If you are an investor in the Netherlands, please go to  

If you are an investor in Italy, please go to  

If you are an investor in Spain, please go to  

If you are an investor in Austria, please go to  

If you are an investor in Germany, please go to   

If you are an investor in Singapore, please go to  

If you are an investor in Switzerland, please go to  

If you are an investor in Belgium, please go to  

If you are an investor in Poland, please go to 

If you are an investor in Norway, please go to

If you are an investor in Denmark, please go to

If you are an investor in Luxembourg, please go to

If you are an investor in Sweden, please go to

If you are an investor in Finland, please go to



The Lyxor ETFs on this website are undertakings for collective investment in transferable securities (UCITS) (i) domiciled in France and approved by the Autorité des Marchés Financiers (AMF) or, (ii) domiciled in Luxembourg, approved by the Commission de Surveillance du Secteur Financier (CSSF) and authorised to market their units or shares in the French Republic in accordance with the notification procedure under Article 93 of Directive 2009/65/EC. Investors should note that the prospectuses of certain Lyxor ETFs under Luxembourg law that have been notified in accordance with this procedure are only available on the website in English. A French translation of these prospectuses can be obtained upon request by sending a letter to Lyxor International Asset Management (“Lyxor”) – 17 Cours Valmy, 92987 Paris La Défense, France.


The information on this website is not intended for persons or entities that are resident, located or registered in jurisdictions that are not authorised to distribute Lyxor ETFs. As a result, the information on this website does not constitute an offer or solicitation to buy or sell units or shares in these ETFs by anyone in any jurisdiction:


(a)   in which such an offer or solicitation is unauthorised;

(b)   in which Lyxor is not qualified to make such an offer or solicitation; or 

(c)   in which it is unlawful to make such an offer or solicitation.


In particular, the Lyxor ETFs on this website are not and will not be registered under the United States Securities Act of 1933, as amended. As such, they may not be offered or sold within the United States of America, except in specific cases where transactions are exempt from registration under the Securities Act. The ETFs listed on this website may not be sold to US citizens or transferred to the United States by any other means, unless this transaction is not subject to any specific registration under US law. 


Any person from a jurisdiction to which the above-mentioned restrictions apply should inform themselves of and observe these restrictions.


This website is intended for commercial purposes and is not regulatory in nature. Although the information provided has been drawn up on the basis of sources considered to be reliable, there is no guarantee that it is accurate, complete or relevant. Some of the information on this website is provided on the basis of market data collected at a specific time and may therefore vary over time. Lyxor advises investors to read the risk factors section of the prospectus and the key investor information document carefully. These documents can be found on the website.


The net asset value (“NAV”) of Lyxor ETFs may at any time be subject to considerable price fluctuations, which in some cases may lead to the loss of all of the capital invested. Investors should note that some ETFs may be sensitive to fluctuations in the exchange rate between their reference currency and that of the underlying index, as well as of the components of the underlying index.


Before investing in a Lyxor ETF, you should carry out your own risk analysis of the product from a legal, tax and accounting perspective, rather than basing your decision solely on the information provided. If necessary, you should consult your own advisers or any other qualified professional. 


Subject to compliance with the legal obligations by which they are bound, Lyxor or any entity within the same group shall not be held liable for any financial or other consequences of an investment in the product. 



By clicking on institutional or individual above, I confirm that I have read and understood the information provided herein, and that I am resident or registered in Luxembourg.


19 Mar 2018

Are Japanese equities ready to rebound?

We wrote at the start of the year that Asia, and countries like Japan, were likely to be this year’s equity hotspots. Abe’s loose policy mix, the implementation of corporate tax reform and the Shunto wage negotiations were all key catalysts.

Many investors seemingly shared our view, helping Japanese equity ETFs enjoy their best ever start to a year with inflows of over €2bn by the end of February. However, the wheels fell off as markets turned. The Nikkei was down by more than 4% YTD at time of writing (15 March), so is the case still intact? 


 Shunto offers some support

Last week, big Japanese companies agreed to raise wages for a fifth successive year after the Shunto – the spring wage negotiations between employers and enterprise unions – concluded. Away from giants like Toyota and Honda, most companies fell shy of the 3% increase targeted by PM Abe and BoJ Governor Kuroda despite tight labour market conditions and historically high profit margins.

The outcome of this year’s negotiations should still help to help drive up domestic consumption, but the rate of wage growth won’t be enough to clear the hurdles hampering the BoJ’s attempts to scale back stimulus. The combination of a negative corporate savings rate and strong wage growth driven by productivity gains – which could draw the deflation era to a definitive end – remains elusive. 


Chart 1 - Japan rebound








Source: Lyxor International Asset Management, Bloomberg. Data as at 15/03/2018





Watch our video 


Kuroda keeps loose

We expect the BoJ to keep policy loose as it strives to hit the 2% inflation target. Its next move may not come until mid-2019, when we expect it to raise its long-term yield target. Yields will therefore be suppressed for a while yet, so JGBs shouldn’t be part of the global trend of rising yields. This should help keep some downward pressure on the yen.  

Advocating Abenomics

One of the main objectives of “Abenomics” was to strengthen corporate profitability. Six years in and it appears to be working. Sales and profit margins are at their highest levels ever. The country’s potential growth rate has increased from around 0.8% in 2012 to around 1.1% - and preparations ahead of the 2020 Olympics in Tokyo should help investment activity pick up speed.   

For the first time in a long time, nominal GDP growth is surpassing long-term yields. To us, this says Abenomics policies have not only helped to weaken the yen and strengthen the economy; they have also delivered at least some of the promised structural reforms. The power to support is now greater than the power to suppress. Economic equilibrium is evolving. 

Shifting structures 

Loose policies and further structural reforms remain likely, with the government set on defeating deflation and increasing productivity by 2020. They’ve already announced programmes designed to enhance social security and education, as well as to increase public infrastructure spending. Investment over the next three years should be more intense in an effort to revolutionise productivity and human resource development.

Further structural shifts - including deregulation and labour market reform - should prompt productivity gains, lift the potential growth rate and make it easier for companies to sustain their profitability.

For all the talk of shift and change, stability matters too. Thankfully, for investors, Abe is likely win in the LDP leadership election this September.

What it all means

Japanese equities have been among the worst of the major equity markets since the start of the year (in local currency terms) – getting caught up in the general turbulence and dragged down by lower corporate earnings growth expectations and a stronger yen. But, with the economy on the mend and the BoJ keeping loose, Japanese equities look attractive to us.

We’re backing them to recover given progress towards reflation and continued profit growth. They are also less sensitive to the yen than perception has it, especially now domestic demand-led growth is gaining traction. 


Chart 2 - Japan rebound

Source: Lyxor International Asset Management, Bloomberg. Data as at 15/03/2018

The road ahead won’t necessarily be smooth - short-term headwinds include a looming end to the loose policy era, possible protectionism and geopolitical risk. Adding some protection of your own may not go amiss. Knowing what you’re exposed to matters more at times like this.  Patience could however pay-off and we’re still very positive on the long-term outlook.


Investing in Japan 

When it comes to choosing your investment vehicle, our analysis could help. In our report at the end of September last year, we found that 44% of active managers outperformed their Japan equity benchmarks over the preceding 12 months. That number drops sharply to 16% over 10 years. It seems that passive tends to win out in the land of the rising sun.

At Lyxor, we have a range of simple Japanese exposures you can choose from – among them some of the largest (the JPX-Nikkei 400) and most efficient (TOPIX) you’ll find*. You can also look to our SG Quality Japan income product for more defensive, domestic-oriented exposures

Source: All data & opinion Lyxor IAM, Lyxor Cross Asset Research, ETF Research & Lyxor Equity ETF teams as at 15 March 2018 unless otherwise stated. Past performance is no guide to future returns. * Data over one year as at 31/01/2018. * Efficiency data is based on the efficiency indicator created by Lyxor‘s research department in 2013. It examines 3 components of performance: tracking error, liquidity and spread purchase/sale. Each peer group includes the relevant Lyxor ETF share-class and the 4 largest ETF share-classes issued by other providers, representing market-share of at least 5% on the relative index. ETF sizes are considered as an average of AUM levels observed over the relevant time period. Detailed methodology may be found in the paper ‘Measuring Performance of Exchange Traded Funds’ by Marlène Hassine and Thierry Roncalli. Statements refer to European ETF market. Past performance is no guide to future returns.

Risk Warning


Fund and charge data: Lyxor ETF, correct as at  05 March 2018.

This document is for the exclusive use of investors acting on their own account and categorized either as “Eligible Counterparties” or “Professional Clients” within the meaning of Markets in Financial Instruments Directive 2004/39/EC. These products comply with the UCITS Directive (2009/65/EC). Société Générale and Lyxor International Asset Management (LIAM) recommend that investors read carefully the “investment risks” section of the product’s documentation (prospectus and KIID). The prospectus and KIID are available free of charge on, and upon request to

The products mentioned are the object of market-making contracts, the purpose of which is to ensure the liquidity of the products on the London Stock Exchange, assuming normal market conditions and normally functioning computer systems. Units of a specific UCITS ETF managed by an asset manager and purchased on the secondary market cannot usually be sold directly back to the asset manager itself. Investors must buy and sell units on a secondary market with the assistance of an intermediary (e.g. a stockbroker) and may incur fees for doing so. In addition, investors may pay more than the current net asset value when buying units and may receive less than the current net asset value when selling them. Updated composition of the product’s investment portfolio is available on In addition, the indicative net asset value is published on the Reuters and Bloomberg pages of the product, and might also be mentioned on the websites of the stock exchanges where the product is listed.

Prior to investing in the product, investors should seek independent financial, tax, accounting and legal advice. It is each investor’s responsibility to ascertain that it is authorised to subscribe, or invest into this product. This document is of a commercial nature and not of a regulatory nature. This material is of a commercial nature and not a regulatory nature. This document does not constitute an offer, or an invitation to make an offer, from Société Générale, Lyxor Asset Management (together with its affiliates, Lyxor AM) or any of their respective subsidiaries to purchase or sell the product referred to herein.

Lyxor International Asset Management (LIAM), société par actions simplifiée having its registered office at Tours Société Générale, 17 cours Valmy, 92800 Puteaux (France), 418 862 215 RCS Nanterre, is authorized and regulated by the Autorité des Marchés Financiers (AMF) under the UCITS Directive (2009/65/EU) and the AIFM Directive (2011/31/EU). LIAM is represented in the UK by Lyxor Asset Management UK LLP, which is authorized and regulated by the Financial Conduct Authority in the UK under Registration Number 435658. Société Générale is a French credit institution (bank) authorised by the Autorité de contrôle prudentiel et de résolution (the French Prudential Control Authority).

Research disclaimer

Lyxor International Asset Management (“LIAM”) or its employees may have or maintain business relationships with companies covered in its research reports. As a result, investors should be aware that LIAM and its employees may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. Please see appendix at the end of this report for the analyst(s) certification(s), important disclosures and disclaimers. Alternatively, visit our global research disclosure website

Conflicts of interest 

This research contains the views, opinions and recommendations of Lyxor International Asset Management (“LIAM”) Cross Asset and ETF research analysts and/or strategists. To the extent that this research contains trade ideas based on macro views of economic market conditions or relative value, it may differ from the fundamental Cross Asset and ETF Research opinions and recommendations contained in Cross Asset and ETF Research sector or company research reports and from the views and opinions of other departments of LIAM and its affiliates. Lyxor Cross Asset and ETF research analysts and/or strategists routinely consult with LIAM sales and portfolio management personnel regarding market information including, but not limited to, pricing, spread levels and trading activity of ETFs tracking equity, fixed income and commodity indices. Trading desks may trade, or have traded, as principal on the basis of the research analyst(s) views and reports. Lyxor has mandatory research policies and procedures that are reasonably designed to (i) ensure that purported facts in research reports are based on reliable information and (ii) to prevent improper selective or tiered dissemination of research reports. In addition, research analysts receive compensation based, in part, on the quality and accuracy of their analysis, client feedback, competitive factors and LIAM’s total revenues including revenues from management fees and investment advisory fees and distribution fees.

Connect with us on linkedin